Lexington-Fayette

FDA Approves COVID-19 Booster for More People – Lexington-Fayette, Kentucky

Lexington-Fayette, Kentucky 2021-10-21 16:37:34 –

More Americans will soon be able to get COVID-19 booster shots.

Boosters are currently available to those who received the Pfizer vaccine at least 6 months ago. Booster recipients must be 65 years of age or older, have potential health risks, or work in a high-risk environment.

On Wednesday, the Food and Drug Administration approved boost immunization for Johnson & Johnson and Moderna vaccinated people.

“Over time, antibodies to the virus appear to gradually decrease. Therefore, the risk of infection increases over time since the vaccine began to rise, but clearly the risk of hospitalization and death. Of greatest concern to those with high risk is Dr. James Nade, who is responsible for infection prevention in the first place. Aurora Medical Center.

Nade said the need and recommendations for boosters are likely to grow over time.

“As effectiveness begins to decline, the risk increases over time,” he explained.

The Food and Drug Administration (FDA) has approved the mixing and matching of vaccine boosters. This was not recommended for the first dose. For example, it was not possible to complete two doses of Pfizer vaccine and get a third booster shot of another brand, such as Moderna.

According to experts, this can be especially useful for those who have been vaccinated with the J & J vaccine. This is because company data show that single-shot prevention is less effective.

“If you have a J & J and get a J & J booster, your antibody levels will definitely rise. They are likely to give you additional protection, but now they will be higher if you get an mRNA booster. I can’t see, “Dr. Neid said.

Dr. Ameshua Dalha, a pandemic specialist and senior scholar at the Johns Hopkins Health and Security Center, said vaccine mixing and matching are relatively rare.

“There isn’t really a mix or match with our existing vaccine, but it’s been considered. For example, in the case of bird flu, it’s an experimental vaccine,” he said. “This is unusual, but what we are trying to do is come up with the best type of vaccine and the best vaccine policy to provide the best protection that people can get. , Highly expected. “

Dr. Nade said most Americans don’t need to get a booster at this moment.

“Most people can start thinking about walking to get boosters, but it’s appropriate to say that they can’t run. Although the number of cases of people vaccinated in hospitals remains very small. , It can change over time, “he said.

He said health leaders and doctors like himself are more focused on getting people vaccinated from the beginning.

“In my sense, the FDA’s priority is to get children aged 5 to 11 to approve the vaccine before lowering the age limit,” said Dr. Neid.



Source link

Back to top button